GPCRs Drug Discovery

G protein-coupled receptors (GPCRs) belong to a great domestic of cell surface signaling proteins that have a pivotal role in many biological functions and in multiple diseases, including the development of cancer and cancer metastasis. Naturally, a number of drugs based on GPCRs have been industrialized for such different indications as cardiovascular, metabolic, neurodegenerative, psychiatric, and oncologic diseases. Owing to the restricted structural information on GPCRs, only limited exploration of structure-based drug design has been possible. Current drugs that target GPCRs - many of which have tremendous therapeutic benefits - are directed towards only a few GPCR members. Therefore, huge determinations are currently proceeding to develop new GPCR-based drugs. We review recent findings that present unexpected opportunities to interfere with main tumorigenic signals by manipulating GPCR-mediated pathways. We also discuss current data concerning novel GPCR targets that may provide talented opportunities for drug discovery in cancer prevention and treatment.

G protein-coupled receptors (GPCRs) belong to a great domestic of cell surface signaling proteins that have a pivotal role in many biological functions and in multiple diseases, including the development of cancer and cancer metastasis. Naturally, a number of drugs based on GPCRs have been industrialized for such different indications as cardiovascular, metabolic, neurodegenerative, psychiatric, and oncologic diseases. Owing to the restricted structural information on GPCRs, only limited exploration of structure-based drug design has been possible. Current drugs that target GPCRs - many of which have tremendous therapeutic benefits - are directed towards only a few GPCR members. Therefore, huge determinations are currently proceeding to develop new GPCR-based drugs. We review recent findings that present unexpected opportunities to interfere with main tumorigenic signals by manipulating GPCR-mediated pathways. We also discuss current data concerning novel GPCR targets that may provide talented opportunities for drug discovery in cancer prevention and treatment.

  • GPCR Signaling
  • Targeting Drug on GPCR
  • Novel Targeting on GPCR
  • GPCR Crystallography in Drug Discovery
  • GPCR Structures in Drug Discovery
  • Tools for GPCR Drug Disocvery
  • Biosensors GPCR Probing Conformation
  • GPCR Screening Method for Drug Discovery

Related Conference of GPCRs Drug Discovery

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

GPCRs Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in